AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medi...(nthe U.S. and abroad including the Alber...),Health

Date:9/3/2007

n the U.S. and abroad including the Albert Einstein Medical Center in Philadelphia, Pennsylvania, Queen of Angels-Hollywood Presbyterian Medical Center, California Medical Center, Cedars-Sinai Medical Center, University of Los Angeles Medical Center, Cochin Hospital in Paris, France and Joffre Hospital in Draveil, France.

He completed his undergraduate work and received his medical degree from the Bobigny Medical School at the University of Paris XIII. He completed his residency in internal medicine and infectious diseases at University of Paris and postdoctoral training at the Laboratory of Pr. Didier Sicard at Cochin University Hospital. He also did another training at Albert Einstein Medical Center.

In addition to undertaking the duties of his new position, Dr. Khanlou will also serve as AHF's Medical Director of Research and will continue as the attending physician at the San Fernando Valley Healthcare Center. AHF's former Chief of Medicine, Charles F. Farthing, M.D., stepped down earlier this year in order to pursue opportunities in the private sector.

AIDS Healthcare Foundation (AHF) is the nation's largest non-profit HIV/AIDS healthcare, research, prevention and education provider, currently provides medical care and/or services to more than 61,000 individuals in 15 countries worldwide in the U.S., Africa, Latin America/Caribbean and Asia. http://www.aidshealth.org.

'/>"/>

SOURCE AIDS Healthcare Foundation Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2
Related medicine technology :

1. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
2. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
3. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
4. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
7. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
8. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
9. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
10. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
11. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients